Joe-elie Salem

Citée par

	Toutes	Depuis 2019
Citations	13141	12605
indice h	51	50
indice i10	133	131

3700

1850

925

2775

20162017201820192020202120222023202439 130 271 778 1635 2325 2946 3603 1236

Accès public

Tout afficher

80 articles

0 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Javid MoslehiUniversity of California, San Francisco (UCSF)Adresse e-mail validée de ucsf.edu
Christian Funck-BrentanoProfesseur Émérite - Faculté de Santé Sorbonne UniversitéAdresse e-mail validée de aphp.fr
Douglas B JohnsonAssociate Professor of Medicine, Vanderbilt University Medical CenterAdresse e-mail validée de vumc.org
Dan RodenProfessor of Medicine and Pharmacology, Vanderbilt UniversityAdresse e-mail validée de vanderbilt.edu
Lee S. NguyenGroupe Hospitalier Privé Ambroise Paré - Hartmann; INSERMAdresse e-mail validée de clinique-a-pare.fr
Jean-Sebastien HulotUniversité de ParisAdresse e-mail validée de aphp.fr
Olivier BenvenisteProfesseur de Médecine Interne et Immunologie Clinique, Sorbonne UniversitéAdresse e-mail validée de aphp.fr
Ali ManouchehriClinical Pharmacology Research Fellow; Vanderbilt University Medical CenterAdresse e-mail validée de vumc.org
Joachim AlexandrePharmacology, MD, PhD, Caen UniversityAdresse e-mail validée de chu-caen.fr
kerneis mathieuCardiology, Hôpital de la Pitié-Salpétrière, AP-HPAdresse e-mail validée de psl.aphp.fr
Justin M. BalkoProfessor of Medicine, and Pathology, Microbiology, and Immunology, Vanderbilt UniversityAdresse e-mail validée de vumc.org
Tao YangVanderbilt UniversityAdresse e-mail validée de vanderbilt.edu
David KlatzmannSorbonne University & Pitié-Salpêtrière HospitalAdresse e-mail validée de sorbonne-universite.fr
Lisa BastaracheVanderbilt University Medical Center - Research Associate ProfessorAdresse e-mail validée de Vanderbilt.Edu
Franck ThunyAix-Marseille University, Department of Cardiology, Nord Hospital, Marseille, FranceAdresse e-mail validée de univ-amu.fr
Andrew MammenNational Institutes of HealthAdresse e-mail validée de nih.gov
Marc Bonaca MD MPHProfessor of Medicine, University of Colorado School of MedicineAdresse e-mail validée de cpcmed.org
Andrew GlazerVanderbilt University Medical CenterAdresse e-mail validée de vumc.org
francoise hidden-lucetmédecin rythmologue APHPAdresse e-mail validée de aphp.fr
Nadia AissaouiMédecine Intensive Réanimation, Hôpital Cochin, Université Paris CitéAdresse e-mail validée de aphp.fr

Suivre

Joe-elie Salem

APHP

Adresse e-mail validée de aphp.fr - Page d'accueil

Clinical Pharmacology - Cardio-Oncology


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis DY Wang, JE Salem, JV Cohen, S Chandra, C Menzer, F Ye, S Zhao, ... JAMA oncology 4 (12), 1721-1728, 2018	1933	2018
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology … AR Lyon, T López-Fernández, LS Couch, R Asteggiano, MC Aznar, ... European Heart Journal-Cardiovascular Imaging 23 (10), e333-e465, 2022	1123	2022
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study JE Salem, A Manouchehri, M Moey, B Lebrun-Vignes, L Bastarache, ... The Lancet Oncology 19 (12), 1579-1589, 2018	863	2018
Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis JJ Moslehi, JE Salem, JA Sosman, B Lebrun-Vignes, DB Johnson The Lancet 391 (10124), 933, 2018	746	2018
Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised … G Cayla, T Cuisset, J Silvain, F Leclercq, S Manzo-Silberman, ... The Lancet 388 (10055), 2015-2022, 2016	394*	2016
Abatacept for severe immune checkpoint inhibitor–associated myocarditis JE Salem, Y Allenbach, A Vozy, N Brechot, DB Johnson, JJ Moslehi, ... New England Journal of Medicine 380 (24), 2377-2379, 2019	340	2019
Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial M Rosenzwajg, R Lorenzon, P Cacoub, HP Pham, F Pitoiset, K El Soufi, ... Annals of the rheumatic diseases 78 (2), 209-217, 2019	332	2019
Statin therapy is associated with lower prevalence of gut microbiota dysbiosis S Vieira-Silva, G Falony, E Belda, T Nielsen, J Aron-Wisnewsky, ... Nature 581 (7808), 310-315, 2020	327	2020
Myocarditis in the setting of cancer therapeutics: proposed case definitions for emerging clinical syndromes in cardio-oncology MP Bonaca, BA Olenchock, JE Salem, SD Wiviott, S Ederhy, A Cohen, ... Circulation 140 (1), 80-91, 2019	315	2019
Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study DB Johnson, A Manouchehri, AM Haugh, HT Quach, JM Balko, ... Journal for immunotherapy of cancer 7, 1-9, 2019	270	2019
Cardiovascular toxicity related to cancer treatment: a pragmatic approach to the American and European cardio‐oncology guidelines J Alexandre, J Cautela, S Ederhy, GL Damaj, JE Salem, F Barlesi, ... Journal of the American Heart Association 9 (18), e018403, 2020	209	2020
Cardiovascular toxicities associated with ibrutinib JE Salem, A Manouchehri, M Bretagne, B Lebrun-Vignes, JD Groarke, ... Journal of the American College of Cardiology 74 (13), 1667-1678, 2019	208	2019
Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin I Gouin‐Thibault, X Delavenne, A Blanchard, V Siguret, JE Salem, ... Journal of Thrombosis and Haemostasis 15 (2), 273-283, 2017	170	2017
Immune checkpoint inhibitor–associated myositis: expanding the spectrum of cardiac complications of the immunotherapy revolution C Anquetil, JE Salem, B Lebrun-Vignes, DB Johnson, AL Mammen, ... Circulation 138 (7), 743-745, 2018	167	2018
A genetic mouse model recapitulates immune checkpoint inhibitor–associated myocarditis and supports a mechanism-based therapeutic intervention SC Wei, WC Meijers, ML Axelrod, NAAS Anang, EM Screever, ... Cancer discovery 11 (3), 614-625, 2021	165	2021
Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes L Genser, D Aguanno, HA Soula, L Dong, L Trystram, K Assmann, ... The Journal of pathology 246 (2), 217-230, 2018	163	2018
Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology A Molinaro, P Bel Lassen, M Henricsson, H Wu, S Adriouch, E Belda, ... Nature Communications 11 (1), 5881, 2020	158	2020
A case report of clonal EBV-like memory CD4⁺ T cell activation in fatal checkpoint inhibitor-induced encephalitis DB Johnson, WJ McDonnell, PI Gonzalez-Ericsson, RN Al-Rohil, ... Nature medicine 25 (8), 1243-1250, 2019	152	2019
Ibrutinib-mediated atrial fibrillation attributable to inhibition of C-terminal Src kinase L Xiao, JE Salem, S Clauss, A Hanley, A Bapat, M Hulsmans, Y Iwamoto, ... Circulation 142 (25), 2443-2455, 2020	143	2020
Sirolimus and mTOR inhibitors: a review of side effects and specific management in solid organ transplantation LS Nguyen, M Vautier, Y Allenbach, N Zahr, O Benveniste, ... Drug safety 42, 813-825, 2019	141	2019

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs